Literature DB >> 21626292

Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer.

Hiroaki Saito1, Tomohiro Osaki, Masahide Ikeguchi.   

Abstract

BACKGROUND: Although malignant diseases are known to be associated with immune suppression, the detailed mechanisms involved are still unknown. NKG2D is an activating cell surface receptor expressed by natural killer (NK) cells and CD8+ T cells, and the engagement of NKG2D is extremely important for NK cell activation. Although decreased NKG2D expression on NK cells is closely related to immune evasion by some cancers, the immunopathological importance of this phenomenon in gastric cancer patients remains unclear.
METHODS: NKG2D expression on NK cells was determined, using multicolor flow cytometry, to investigate the mechanisms responsible for immune evasion in gastric cancer patients.
RESULTS: NKG2D expression on NK cells from gastric cancer patients was significantly lower than that in healthy controls. Also, NKG2D expression in advanced gastric cancer was significantly lower than that in early gastric cancer. NK cells from patients with lymph node metastasis expressed significantly lower levels of NKG2D than the NK cells from those without lymph node metastasis, and NKG2D expression on NK cells in gastric cancer tissue was significantly lower than that of circulating NK cells. NKG2D expression on NK cells obtained from cancer patients was restored after 48 h in culture with RPMI containing 10% AB serum. Furthermore, NKG2D expression on NK cells obtained after surgery was significantly higher than that before surgery.
CONCLUSIONS: Decreased NKG2D expression on NK cells may be one of the key mechanisms responsible for NK cell dysfunction in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626292     DOI: 10.1007/s10120-011-0059-8

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  42 in total

Review 1.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.

Authors:  Masahisa Jinushi; F Stephen Hodi; Glenn Dranoff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

Review 3.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

4.  Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis.

Authors:  H Takeuchi; Y Maehara; E Tokunaga; T Koga; Y Kakeji; K Sugimachi
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

5.  Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer.

Authors:  A Takahashi; K Kono; H Amemiya; H Iizuka; H Fujii; Y Matsumoto
Journal:  Clin Cancer Res       Date:  2001-01       Impact factor: 12.531

6.  Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells.

Authors:  M E Nunn; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1979-04       Impact factor: 13.506

7.  Decreased natural cytotoxicity in mice with high incidence of mammary adenocarcinoma.

Authors:  I H Ames; A M Garcia; P A John; C A Litty; M A Farrell; R H Tomar
Journal:  Clin Immunol Immunopathol       Date:  1986-02

8.  Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects.

Authors:  Christophe Borg; Magali Terme; Julien Taïeb; Cédric Ménard; Caroline Flament; Caroline Robert; Koji Maruyama; Hiro Wakasugi; Eric Angevin; Kris Thielemans; Axel Le Cesne; Véronique Chung-Scott; Vladimir Lazar; Isabelle Tchou; Florent Crépineau; François Lemoine; Jacky Bernard; Jonhantan A Fletcher; Ali Turhan; Jean-Yves Blay; Alain Spatz; Jean-François Emile; Michael C Heinrich; Salah Mécheri; Thomas Tursz; Laurence Zitvogel
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

9.  Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

Authors:  T Barlozzari; J Leonhardt; R H Wiltrout; R B Herberman; C W Reynolds
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

10.  Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.

Authors:  N L Vujanovic; R B Herberman; A A Maghazachi; J C Hiserodt
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Role of NKG2D and its ligands in cancer immunotherapy.

Authors:  Huifang Liu; Sijia Wang; Jing Xin; Jing Wang; Cuiping Yao; Zhenxi Zhang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

2.  Hemacytotoxicity and natural killer lytic index: New parameters to evaluate natural killer cell immunity for clinical use in cancer.

Authors:  Hyung Gun Maeng; Su Jin Lee; Yun A Lee; Hye Jeong Lee; Young Joo Kim; Jong Kyun Lee; Jae Cheol Kim; Joungbum Choi
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

3.  PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients.

Authors:  Fernando Concha-Benavente; Benjamin Kansy; Jessica Moskovitz; Jennifer Moy; Uma Chandran; Robert L Ferris
Journal:  Cancer Immunol Res       Date:  2018-10-03       Impact factor: 11.151

Review 4.  Organ-specific phenotypic and functional features of NK cells in humans.

Authors:  Richa Sharma; Asmita Das
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

5.  Cryopreserved NK cells in the treatment of haematological malignancies: preclinical study.

Authors:  Monika Holubova; Michaela Miklikova; Martin Leba; Daniel Georgiev; Pavel Jindra; Martin Caprnda; Rachele Ciccocioppo; Peter Kruzliak; Daniel Lysak
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-10       Impact factor: 4.553

Review 6.  Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer.

Authors:  Hui-Ying Ma; Xin-Zhou Liu; Chun-Min Liang
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

7.  Intracellular poly(I:C) initiated gastric adenocarcinoma cell apoptosis and subsequently ameliorated NK cell functions.

Authors:  Jing Qu; Zhaohua Hou; Qiuju Han; Wen Jiang; Cai Zhang; Zhigang Tian; Jian Zhang
Journal:  J Interferon Cytokine Res       Date:  2013-09-13       Impact factor: 2.607

8.  Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.

Authors:  Chuang Zhang; Danni Li; Ruoxi Yu; Ce Li; Yujia Song; Xi Chen; Yibo Fan; Yunpeng Liu; Xiujuan Qu
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

9.  Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity.

Authors:  Minh Ngoc Duong; Aurore Cleret; Eva-Laure Matera; Kamel Chettab; Doriane Mathé; Sandrine Valsesia-Wittmann; Béatrice Clémenceau; Charles Dumontet
Journal:  Breast Cancer Res       Date:  2015-04-24       Impact factor: 6.466

10.  Influence of tumors on protective anti-tumor immunity and the effects of irradiation.

Authors:  Gemma A Foulds; Jürgen Radons; Mira Kreuzer; Gabriele Multhoff; Alan G Pockley
Journal:  Front Oncol       Date:  2013-02-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.